![](/img/cover-not-exists.png)
Pegylated interferon alfa-2a in patients with essential thrombocythaemia or polycythaemia vera: a post-hoc, median 83 month follow-up of an open-label, phase 2 trial
Masarova, Lucia, Patel, Keyur P, Newberry, Kate J, Cortes, Jorge, Borthakur, Gautam, Konopleva, Marina, Estrov, Zeev, Kantarjian, Hagop, Verstovsek, SrdanVolume:
4
Language:
english
Journal:
The Lancet Haematology
DOI:
10.1016/S2352-3026(17)30030-3
Date:
April, 2017
File:
PDF, 1.48 MB
english, 2017